MedTrace Logo

Chronic GVHD Response Measures Validation

NCT01902576 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 383

Last updated 2026-03-20

No results posted yet for this study

Summary

The purpose of this study is to develop and validate endpoint measures that can accurately determine whether patients are responding to treatment for chronic Graft-versus-Host Disease (GVHD). Hopefully, this will also lead to being better able to predict which patients will respond to what therapies.

Conditions

  • Graft vs Host Disease

Sponsors & Collaborators

  • Fred Hutchinson Cancer Center

    lead OTHER

Principal Investigators

  • Stephanie J Lee, MD MPH · Fred Hutchinson Cancer Center

Eligibility

Min Age
7 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2019-09-26
Completion
2027-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01902576 on ClinicalTrials.gov